PerillaOil (Perilla frutescens)

Perilla oil, cold-pressed from Perilla frutescens seeds, is one of the richest plant-based sources of alpha-linolenic acid (ALA), an omega-3 fatty acid comprising 54–64% of its fatty acid profile. ALA undergoes enzymatic conversion via delta-6-desaturase and elongase enzymes toward EPA and DHA, supporting anti-inflammatory eicosanoid signaling pathways.

Origin & History

Perilla oil is derived from the seeds of Perilla frutescens, an annual herb native to East Asia, particularly China, Japan, and Korea. It is extracted through methods such as subcritical butane extraction at 55-65°C and 0.9-1.1 MPa for 6-8 hours, or ultrasound-assisted aqueous enzymatic extraction (UAAEE).

Historical & Cultural Context

The research provides no specific information about traditional or historical medicinal uses of perilla oil. While the plant is noted in East Asian agricultural contexts, no details on traditional medicine systems or historical applications are documented.

Health Benefits

• Limited clinical evidence available - no human trials documented in the research
• Antioxidant properties noted in laboratory studies only
• Antibacterial activity observed in vitro from leaf/seed extracts
• Rich source of polyunsaturated fatty acids based on chemical composition analysis
• No specific health benefits verified through human clinical trials

How It Works

Perilla oil's primary bioactive compound, alpha-linolenic acid (ALA), competes with arachidonic acid for cyclooxygenase (COX) and lipoxygenase (LOX) enzymes, reducing synthesis of pro-inflammatory prostaglandin E2 (PGE2) and leukotriene B4 (LTB4). ALA is converted via delta-6-desaturase to stearidonic acid and subsequently elongated to EPA, which serves as a substrate for anti-inflammatory resolvins and protectins. Additionally, rosmarinic acid and luteolin present in perilla leaf extracts inhibit NF-κB signaling, further modulating inflammatory cytokine transcription.

Scientific Research

No human clinical trials, RCTs, or meta-analyses on perilla oil were found in the available research. Evidence is limited to in vitro assessments of chemical compositions and extraction optimizations without human trial data or PubMed PMIDs.

Clinical Summary

Human clinical evidence specifically for perilla oil supplementation is extremely limited, with no large-scale randomized controlled trials documented as of current literature. Observational and small pilot studies suggest that diets enriched in ALA-rich oils may correlate with modest reductions in LDL cholesterol and inflammatory markers such as C-reactive protein, though perilla oil has not been independently validated at defined doses. In vitro and animal studies using perilla seed or leaf extracts demonstrate antioxidant activity, antibacterial effects against Staphylococcus aureus and E. coli, and suppression of allergic mediator release from mast cells, but these findings cannot be directly extrapolated to human supplementation outcomes. Overall, the evidence base for perilla oil as a standalone supplement remains preliminary, and it should currently be regarded as a theoretical omega-3 source rather than a clinically validated therapeutic agent.

Nutritional Profile

Perilla oil is extracted from the seeds of Perilla frutescens and is composed almost entirely of fat (~100% lipid content by weight as a refined oil). Its defining characteristic is an exceptionally high alpha-linolenic acid (ALA, omega-3) content, typically ranging from 54–64% of total fatty acids, making it one of the richest plant-based sources of ALA. Remaining fatty acids include linoleic acid (omega-6) at approximately 14–20%, oleic acid (omega-9) at 12–18%, palmitic acid (saturated) at 5–7%, and stearic acid (saturated) at 1–3%, yielding a highly favorable omega-3 to omega-6 ratio of approximately 4:1 to 6:1. As a fat source, it provides approximately 884 kcal per 100g with negligible protein, carbohydrates, and fiber. Micronutrient content includes vitamin E (tocopherols), primarily gamma-tocopherol at approximately 30–50 mg per 100g, which contributes to oxidative stability. Bioactive compounds include rosmarinic acid, luteolin, and apigenin (predominantly in leaf extracts rather than refined oil), as well as phytosterols (beta-sitosterol, campesterol) at approximately 200–400 mg per 100g. Polyphenolic content is largely removed during commercial oil refining. Bioavailability note: ALA from perilla oil is absorbed efficiently via the lymphatic system as with other dietary fats, but conversion to longer-chain omega-3s (EPA, DHA) in humans is metabolically limited, typically less than 5–10% conversion to EPA and under 1% to DHA, consistent with all plant-based ALA sources.

Preparation & Dosage

No clinically studied dosage ranges have been established for perilla oil in any form. Manufacturing parameters describe extraction ratios like 1 kg perilla powder to 5 L butane, but these are not therapeutic doses. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other omega-3 sources, vitamin E, antioxidant compounds

Safety & Interactions

Perilla oil is generally considered safe when consumed in culinary amounts, but supplemental doses have not been rigorously evaluated for safety in controlled human trials. Individuals taking anticoagulant medications such as warfarin or antiplatelet drugs like clopidogrel should exercise caution, as high ALA intake may additively inhibit platelet aggregation and prolong bleeding time. Perilla leaf extracts containing perillaldehyde have demonstrated contact sensitization potential in some individuals, and those with known plant-family (Lamiaceae) allergies should consult a physician before use. Pregnant and breastfeeding women should avoid supplemental doses beyond dietary amounts due to insufficient safety data, though food-level consumption is not documented to pose harm.